ReviewJournal of neuroinflammation2026
Airborne particulate matter and the lung-brain axis: unraveling the neuroinflammatory cascade from alveolar irritation to microglial activation.
Review in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sedation as an Immunomodulator of Inflammatory Responses in the Lung-Brain Axis of ARDS.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundEpidemiological evidence increasingly substantiates a correlation between chronic exposure to airborne environmental pollutants—specifically fine particulate matter (PM₂.₅) and diesel exhaust particles—and the prevalence of neurological disorders. While the respiratory consequences of these exposures are well-documented, the mechanisms by which pulmonary distress communicates pathogenic signals to the central nervous system remain complex and multifaceted. SCOPE & REVIEW: This review explores the "Lung-Brain Axis" as a critical conduit for neurotoxicity. We synthesize current findings on two primary pathways: (1) the direct translocation of ultrafine particles via the olfactory nerve and compromised blood-brain barrier (BBB), and (2) the indirect "spill-over" hypothesis, where pulmonary-derived pro-inflammatory cytokines (e.g., IL-1β, TNF-α, IL-6) and extracellular vesicles (EVs) propagate systemic inflammation that subsequently primes microglial activation in the brain. KEY MECHANISMS: We detail the molecular interplay between alveolar macrophages and the subsequent polarization of neuroimmune cells. Special attention is given to the role of the vagus nerve in sensing pulmonary inflammation and the potential involvement of lung-derived exosomes in transporting microRNAs that disrupt neuronal homeostasis.
conclusionUnderstanding the specific molecular messengers of the lung-brain axis is essential for developing therapeutic strategies. Targeting the pulmonary inflammatory response may offer a novel prophylactic approach to mitigate the neurological burden of environmental pollution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.